Takeda_TAK-788-3001 app icon

Apps Like Takeda_TAK-788-3001 for iPhone and iPad

by ERT, INC★ 0.00 ratingsMedicalFreeData updated 2026-09-22

Takeda_TAK-788-3001 screenshots

Ranked alternatives

Showing 481–500 of 1,000 ranked alternatives.

  1. CeQOL – Inguinal Hernia app icon

    CeQOL – Inguinal Hernia

    Carolinas Surgical Innovation Group, LLC

    Predicting quality of life after surgery.

    The app predicts the incidence of chronic pain following inguinal hernia repair in males. Users answer 18 questions to receive a percentage chance of discomfort one year after surgery.

    ★ 4.52 ratingsMedicalFreeData updated 2026-10-04
  1. PatientGO app icon

    PatientGO

    Illingworth Research Group Ltd

    ★ 1.02 ratingsMedicalFreeData updated 2026-09-29
  2. Hem/Onc @Point of Care app icon

    Hem/Onc @Point of Care

    At Point of Care, LLC

    Access patient data and track progress

    Access curated, evidence-based medical content for hematology and oncology. Use voice-enabled navigation to search for disease-specific information. Track patient progress and receive clinical decision support.

    ★ 5.02 ratingsMedicalFreeData updated 2026-09-12
  3. Purview Patient Access app icon

    Purview Patient Access

    Nimble CO LLC

    View medical images securely

    View and manage medical images such as CT, MRI, ultrasound, X-ray, and PET scans. Share images securely via email, text, or WhatsApp. DICOM files without needing a CD.

    ★ 5.02 ratingsMedicalFreeData updated 2026-09-06
  4. AI in Cardiovascular Medicine app icon

    AI in Cardiovascular Medicine

    Medical Software, LLC

    Assess heart conditions and recommend treatments

    Assessment tool for heart and vascular disease. Provides diagnostic and therapeutic recommendations based on guidelines and trial data. Generates evidence-based solutions tailored to individual patients.

    ★ 5.01 ratingsMedicalFreeData updated 2026-09-16

How we rank alternatives

Apps are ranked by functional similarity, category fit, rating confidence, and popularity.